Targeting HIV in initial stages of infection may prevent virus from spreadingFebruary 18th, 2009 - 2:22 pm ICT by ANI
London, Feb 18 (ANI): A new study suggests that vaccines, which specifically target HIV in the initial stages of infection before it becomes a rapidly replicating, system-wide infection, may be a successful approach in limiting the spread of the disease.
Researchers at Oregon Health & Science University’’s Vaccine and Gene Therapy Institute used a vaccination method that involves creating and maintaining resistance by programming a portion of the body’’s immune system effector memory T-cells to look out for HIV at the site of infection.
“HIV appears to be vulnerable when it is first introduced into mucosal surfaces in the body,” said Louis Picker, M.D., associate director of the OHSU VGTI and director of the VGTI’’s vaccine program.
“However, once HIV spreads throughout the entire body, it replicates very rapidly and becomes difficult if not impossible to control. Our approach is to attack during this early period of vulnerability. The approach is similar to that of a homeowner who sprays their house with water before sparks land on the roof. This approach can prevent the roof from catching fire and, in the case of HIV, prevent the spread of the virus,” Picker added.
To determine whether they could proactively “educate” the immune system, scientists used a monkey model of AIDS - simian immunodeficiency virus (SIV) the monkey counterpart to HIV.
They introduced an altered monkey form of cytomegalovirus (CMV) programmed to express SIV proteins and trigger specialized effector memory T-cells to look for and attack SIV in its early stages.
In total, 12 rhesus macaque monkeys were vaccinated using this method. When the animals were later infected with SIV, one-third were protected.
The research teams next step is to try to determine why only a portion of the monkeys who are vaccinated using this method are responding.
They also hope to expand the number of subjects to better determine the success rate of the therapy.
The research is published in the early online edition of the journal Nature Medicine. (ANI)
- Monkey jab may open way for HIV vaccine - May 12, 2011
- New genetic strategy makes T-cells resistant to HIV infection - Jan 27, 2011
- Original HIV infection holds its sway despite numerous changes - Jun 30, 2010
- Rabies vaccine offers hope for AIDS vaccine - Dec 15, 2009
- Monkey version of HIV older than previously believed - May 22, 2010
- Long history of SIV indicates HIV won't quickly become benign in humans - May 22, 2010
- HIV may soon fight HIV - Feb 19, 2010
- New treatment method may possibly eradicate HIV infection - Jun 22, 2009
- Promising target for AIDS vaccine identified - Apr 01, 2011
- New approach for targeted killing of HIV virus - Aug 19, 2010
- New approach may pave way for effective HIV vaccine - May 18, 2009
- New strategies proposed for AIDS vaccine research - Aug 08, 2009
- New research may expand drug arsenal used to fight HIV - Mar 09, 2010
- Fresh hope for HIV patients - Mar 09, 2010
- Why some monkeys are resistant to AIDS - Jun 30, 2010
Tags: associate director, cmv, counterpart, disease researchers, gene therapy, hiv, immune system, initial stages, london feb, mucosal surfaces, oregon health, proteins, rhesus macaque monkeys, science university, t cells, vaccination, vaccine program, vaccines, vgti, vulnerability